Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Prime Medicine Inc (NASDAQ: PRME) closed at $5.57 in the last session, up 3.15% from day before closing price of $5.40. In other words, the price has increased by $3.15 from its previous closing price. On the day, 0.67 million shares were traded. PRME stock price reached its highest trading level at $5.59 during the session, while it also had its lowest trading level at $5.25.
Ratios:
We take a closer look at PRME’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.53 and its Current Ratio is at 2.53. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on April 22, 2024, initiated with a Buy rating and assigned the stock a target price of $17.
On April 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $12.Wedbush initiated its Outperform rating on April 03, 2024, with a $12 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 15 ’24 when ARCH Venture Partners XII, LLC bought 3,200,000 shares for $6.25 per share. The transaction valued at 20,000,000 led to the insider holds 3,200,000 shares of the business.
ARCH Venture Partners X, LLC bought 3,200,000 shares of PRME for $20,000,000 on Feb 15 ’24. The 10% Owner now owns 3,200,000 shares after completing the transaction at $6.25 per share. On Feb 15 ’24, another insider, NELSEN ROBERT, who serves as the Director of the company, bought 3,200,000 shares for $6.25 each. As a result, the insider paid 20,000,000 and bolstered with 3,200,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRME now has a Market Capitalization of 668561536 and an Enterprise Value of 533650112.
Stock Price History:
Over the past 52 weeks, PRME has reached a high of $17.20, while it has fallen to a 52-week low of $4.11. The 50-Day Moving Average of the stock is -14.67%, while the 200-Day Moving Average is calculated to be -35.04%.
Shares Statistics:
According to the various share statistics, PRME traded on average about 775.27K shares per day over the past 3-months and 931670 shares per day over the past 10 days. A total of 97.38M shares are outstanding, with a floating share count of 49.81M. Insiders hold about 58.50% of the company’s shares, while institutions hold 24.51% stake in the company. Shares short for PRME as of 1713139200 were 10213643 with a Short Ratio of 13.17, compared to 1710460800 on 9666173. Therefore, it implies a Short% of Shares Outstanding of 10213643 and a Short% of Float of 17.879998999999998.
